Bridge to Life Divests Certain Assets to TransMedics
Comunicato Precedente
Comunicato Successivo
Piper Sandler & Co. acted as financial advisor to Bridge to Life. Canaccord Genuity LLC acted as financial advisor to TransMedics. Cooley LLP acted as legal advisor to Bridge to Life. Ropes & Gray LLP acted as legal advisor to TransMedics.
For more than a decade, Bridge to Life Ltd. has set the standard of care by providing the transplant community with the gold standard Belzer UW® preservation solutions along with other core products including EasiSlush®. The company also recently announced promising interim pivotal study results for its VitaSmart™ Liver perfusion device and completed enrollment in the Bridge to HOPE Liver Clinical Trial well ahead of schedule. The Company is setting a new standard in hypothermic oxygenated machine perfusion with the unique HOPE protocol developed with leading international organ transplant surgeons. Through developing highly efficacious and sustainable technologies, Bridge to Life remains steadfast in its ongoing mission to alleviate organ transplant waiting lists by ensuring equitable access to these new innovative technologies for all patients.
Logo - https://mma.prnewswire.com/media/2085277/Bridge_to_Life_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/bridge-to-life-divests-certain-assets-to-transmedics-301892049.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
